We are conducting a new project and are looking to speak to Specialists Nurses. The purpose of the research is to understand more about the needs of patients diagnosed with metastatic renal cell carcinoma. The sponsoring pharmaceutical would like to use these learnings to develop effective, meaningful support offerings for mRCC patients. The research will take the form of a 75-minute web-assisted telephone interview. To take part in this study, please click on the button below.